Pharma BD Deal Intelligence

The Deal Library

Browse 1,275 pharma and biotech BD deals, $5160.3B in disclosed deal value, 875 with a post-close Outcome Score, organized by year, acquirer, and therapeutic area. Each deal is graded on announcement reception and post-close outcome.

Interactive search & filters  ·  How we score deals

By year

• 2026 (119)
• 2025 (59)
• 2024 (62)
• 2023 (61)
• 2022 (56)
• 2021 (66)
• 2020 (62)
• 2019 (69)
• 2018 (43)
• 2017 (47)
• 2016 (57)
• 2015 (56)
• 2014 (54)
• 2013 (46)
• 2012 (38)
• 2011 (36)
• 2010 (44)
• 2009 (35)
• 2008 (25)
• 2007 (30)
• 2006 (37)
• 2005 (36)
• 2004 (17)
• 2003 (23)
• 2002 (23)
• 2001 (33)
• 2000 (21)
• 1999 (4)
• 1998 (3)
• 1997 (1)
• 1996 (1)
• 1995 (4)
• 1994 (3)
• 1991 (1)
• 1989 (1)
• 1974 (1)
• 1895 (1)

By acquirer

• Abbott Laboratories (15)
• AbbVie Inc. (37)
• Alexion Pharmaceuticals, Inc. (3)
• Allergan plc (11)
• Amgen Inc. (17)
• Astellas Pharma Inc. (11)
• AstraZeneca PLC (45)
• AstraZeneca plc (6)
• AstraZeneca PLC (Alexion) (3)
• Bayer AG (23)
• Biogen Inc. (8)
• BioNTech SE (4)
• Boehringer Ingelheim GmbH (6)
• Boehringer Ingelheim International GmbH (5)
• Boston Scientific Corporation (4)
• Bristol-Myers Squibb Company (50)
• Celgene Corporation (13)
• Cephalon Inc. (7)
• Cephalon, Inc. (6)
• Daiichi Sankyo Company, Limited (4)
• Danaher Corporation (3)
• Eli Lilly and Company (63)
• Endo Health Solutions Inc. (4)
• Endo International plc (4)
• Endo Pharmaceuticals Holdings Inc. (5)
• Genmab A/S (3)
• Genzyme Corporation (5)
• Gilead Sciences Inc. (14)
• Gilead Sciences, Inc. (5)
• GlaxoSmithKline plc (25)
• GSK plc (22)
• Horizon Pharma plc (3)
• Hospira, Inc. (3)
• Illumina, Inc. (3)
• Incyte Corporation (6)
• Inverness Medical Innovations Inc. (3)
• Ipsen S.A. (6)
• Jazz Pharmaceuticals PLC (4)
• Johnson & Johnson (27)
• King Pharmaceuticals Inc. (3)
• Mallinckrodt plc (6)
• Merck & Co. Inc. (48)
• Merck & Co., Inc. (3)
• Merck KGaA (8)
• Mylan Inc. (5)
• Mylan Laboratories Inc. (4)
• Mylan N.V. (5)
• Novartis AG (52)
• Novo Nordisk A/S (13)
• Nycomed (3)
• Otsuka Pharmaceutical Co., Ltd. (4)
• Pfizer Inc. (61)
• Regeneron Pharmaceuticals, Inc. (4)
• Roche Holding AG (62)
• Sanofi SA (53)
• Sanofi-Aventis (4)
• Schering-Plough Corp. (3)
• Servier (3)
• Servier SA (3)
• Shire plc (11)
• Stryker Corporation (4)
• Sumitomo Dainippon Pharma Co., Ltd. (3)
• Sun Pharmaceutical Industries Ltd. (5)
• Swedish Orphan Biovitrum AB (3)
• Takeda Pharmaceutical Company Limited (9)
• Takeda Pharmaceutical Company Ltd. (12)
• Teva Pharmaceutical Industries Ltd. (17)
• Thermo Fisher Scientific Inc. (6)
• UCB S.A. (4)
• Valeant Pharmaceuticals International (3)
• Valeant Pharmaceuticals International, Inc. (5)
• Vertex Pharmaceuticals Inc. (5)
• Vertex Pharmaceuticals Incorporated (7)
• Watson Pharmaceuticals Inc. (4)
• Watson Pharmaceuticals, Inc. (4)

By therapeutic area

• Cardiovascular (80)
• Dermatology (51)
• Gastroenterology (42)
• Gene Therapy (24)
• Hematology (84)
• Immunology (81)
• Infectious Disease (68)
• Metabolic (46)
• Multiple (undisclosed) (33)
• Nephrology (17)
• Neurology (107)
• Oncology (251)
• Ophthalmology (15)
• Other (81)
• Rare Disease (26)
• Respiratory (25)
• Vaccines (11)
• Women's Health (8)